FDA 483 - K. W. Griffen Company DBA Biomed Packaging Systems - March 15, 2024
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
K. W. Griffen Company DBA Biomed Packaging Systems in Norwalk, CT, was cited for multiple failures related to adverse drug experience (ADE) reporting and record-keeping. The inspection revealed a lack of written procedures for ADE surveillance and reporting, along with failures to submit periodic and annual reports and maintain ADE records for the required duration. These issues indicate significant deficiencies in the firm's post-marketing drug surveillance and regulatory compliance.
- Inspection Date
- March 15, 2024
- Product Type
- Drugs
- Person
ID · 3512597a-e8ba-4098-a378-a0a8dfbe25c5